Scot Styren

3.6k citations

31 papers · 2.9k indexed · 2 hit papers · h-index 19

Impact in

Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
Biological Psychiatry top 1%
- Tryptophan and brain disorders

Papers in ⓘ

Physiology 18
- Alzheimer's disease research and treatments 18
Molecular Biology 7
- S100 Proteins and Annexins 4

Co-authors: Steven T. DeKosky (12 shared papers)Joseph Rogers (4 shared papers)W H Civin (3 shared papers)Judith Luber‐Narod (1 shared paper)Stephen W. Scheff (1 shared paper)Patrick M. Kochanek (5 shared papers)William E. Klunk (2 shared papers)Jeffrey H. Kordower (2 shared papers)
Journals: Alzheimer s & Dementia (6 papers)Experimental Neurology (3 papers)Alzheimer s & Dementia Translational Research & Clinical Interventions (3 papers)Brain Research (2 papers)Neurobiology of Aging (2 papers)
Partner nations: United States Belgium South Korea

In The Last Decade

Scot Styren

30 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment 2002 · 560 citations

Peers

Countries citing papers authored by Scot Styren

Since Specialization

Citations

This map shows the geographic impact of Scot Styren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot Styren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot Styren more than expected).

Fields of papers citing papers by Scot Styren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot Styren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot Styren. The network helps show where Scot Styren may publish in the future.

Co-authors

The 25 scholars most cited alongside Scot Styren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scot Styren Line = papers co-authored together Scot Styren links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease Neurobiology of Aging ·Joseph Rogers, Judith Luber‐Narod, Scot Styren, W H Civin Hit paper breakdown →	1988	601
2	Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment Annals of Neurology ·Steven T. DeKosky, Miloš D. Ikonomović, Scot Styren, Laurel Beckett, Stephen R. Wisniewski, David A. Bennett, Elizabeth J. Cochran, Jeffrey H. Kordower, Elliott J. Mufson Hit paper breakdown →	2002	560
3	Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change PubMed ·Steven T. DeKosky, Stephen W. Scheff, Scot Styren	1996	330
4	X-34, A Fluorescent Derivative of Congo Red: A Novel Histochemical Stain for Alzheimer's Disease Pathology Journal of Histochemistry & Cytochemistry ·Scot Styren, Ronald L. Hamilton, Gisele C. Styren, William E. Klunk	2000	230
5	Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain Experimental Neurology ·Scot Styren, W H Civin, Joseph Rogers	1990	152
6	Hypothermia Attenuates the Normal Increase in Interleukin 1β RNA and Nerve Growth Factor Following Traumatic Brain Injury in the Rat Journal of Neurotrauma ·James R. Goss, Scot Styren, Peter D. Miller, Patrick M. Kochanek, Alan M. Palmer, Donald W. Marion, Steven T. DeKosky	1995	138
7	Astrocytes Are the Major Source of Nerve Growth Factor Upregulation Following Traumatic Brain Injury in the Rat Experimental Neurology ·James R. Goss, Mark E. O’Malley, Lanling Zou, Scot Styren, Patrick M. Kochanek, Steven T. DeKosky	1998	130
8	Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34 Neurobiology of Aging ·Christopher D. Link, Carolyn J. Johnson, Virginia Fonte, Marie-Christine Paupard, David H. Hall, Scot Styren, Chester A. Mathis, William E. Klunk	2001	126
9	Upregulation of Nerve Growth Factor Following Cortical Trauma Experimental Neurology ·Steven T. DeKosky, James R. Goss, Peter D. Miller, Scot Styren, Patrick M. Kochanek, Donald W. Marion	1994	104
10	Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain Annals of Neurology ·Steven T. DeKosky, Scot Styren, Mark E. O’Malley, James R. Goss, Patrick M. Kochanek, Donald W. Marion, Christopher H. Evans, Paul D. Robbins	1996	84
11	Fetal Grafting for Parkinson's Disease: Expression of Immune Markers in Two Patients with Functional Fetal Nigral Implants Cell Transplantation ·Jeffrey H. Kordower, Scot Styren, Martha Clarke, Steven T. DeKosky, C. Warren Olanow, Thomas B. Freeman	1997	60
12	Preservation of Brain Nerve Growth Factor in Mild Cognitive Impairment and Alzheimer Disease Archives of Neurology ·Elliott J. Mufson, Miloš D. Ikonomović, Scot Styren, Scott Counts, Joanne Wuu, Sue E. Leurgans, David A. Bennett, Elizabeth J. Cochran, Steven T. DeKosky	2003	51
13	Expression of differential immune factors in temporal cortex and cerebellum: The role of ?-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease The Journal of Comparative Neurology ·Scot Styren, M. Ilyas Kamboh, Steven T. DeKosky	1998	50
14	Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy Alzheimer s & Dementia Translational Research & Clinical Interventions ·Jaren W. Landen, Sharon Cohen, Clare B. Billing, Carol Cronenberger, Scot Styren, Aaron H. Burstein, Catherine Sattler, Jae‐Hong Lee, Clifford R. Jack, Kejal Kantarci, Pamela F. Schwartz, William Duggan, Qinying Zhao, Ken Sprenger, Martin M. Bednar, Brendon Binneman	2017	50
15	Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease Clinical Neuropharmacology ·Aaron H. Burstein, Qinying Zhao, Joel Ross, Scot Styren, Jaren W. Landen, Weidong Wendy, Fred McCush, Christine Alvey, James W. Kupiec, Martin M. Bednar	2013	43
16	Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies Alzheimer s Research & Therapy ·Adrian Ivanoiu, Jérémie Pariente, Kevin Booth, Kasia Lobello, Gérald Luscan, Lisa Hua, Prisca Lucas, Scot Styren, Lingfeng Yang, David Li, Ronald S. Black, H. Robert Brashear, Thomas McRae	2016	33
17	Epidermal growth factor receptor expression in demented and aged human brain Brain Research ·Scot Styren, Elliot J. Mufson, Gisele C. Styren, W H Civin, Joseph Rogers	1990	30
18	Up‐Regulation of Type 2 Iodothyronine Deiodinase mRNA in Reactive Astrocytes Following Traumatic Brain Injury in the Rat Journal of Neurochemistry ·Lanling Zou, Lynn A. Burmeister, Scot Styren, Patrick M. Kochanek, Steven T. DeKosky	1998	26
19	P1‐012: Effect of ponezumab on CSF biomarkers: Pooled analysis of phase IIa studies in subjects with mild‐to‐moderate Alzheimer's disease Alzheimer s & Dementia ·Carol Cronenberger, Pam Schwartz, Kathryn Wright, Kelly R. Bales, Kaj Blennow, Henrik Zetterberg, Jaren W. Landen, Scot Styren, Nathan Chen, Brendon Binneman	2012	18
20	Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin Brain Research ·Scot Styren, Steven T. DeKosky, Joseph Rogers, E. J. Mufson	1993	17

About Scot Styren

Scot Styren is a scholar working on Physiology, Molecular Biology, Neurology, Psychiatry and Mental health and Neurology, having authored 31 papers that have together received 2.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), S100 Proteins and Annexins (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Tryptophan and brain disorders (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Neurology (885 citations), Biological Psychiatry (257 citations), Physiology (1.6k citations), Developmental Neuroscience (194 citations) and Aging (74 citations). Scot Styren has collaborated with scholars based in United States, Belgium and South Korea. Frequent co-authors include Steven T. DeKosky, Joseph Rogers, W H Civin, Judith Luber‐Narod, Stephen W. Scheff, Patrick M. Kochanek, William E. Klunk, Jeffrey H. Kordower, James R. Goss and Elliott J. Mufson. Their work appears in journals such as Alzheimer s & Dementia, Experimental Neurology, Alzheimer s & Dementia Translational Research & Clinical Interventions, Brain Research and Neurobiology of Aging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact